We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWO icon
226
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$4.46M 0.07%
97,063
-1,438
-1% -$64.3K
VOO icon
227
Vanguard S&P 500 ETF
VOO
$968B
$4.42M 0.06%
18,031
+675
+4% +$161K
PAYX icon
228
Paychex
PAYX
$40.4B
$4.41M 0.06%
64,809
+2,270
+4% +$149K
IPG
229
DELISTED
Interpublic Group of Companies
IPG
$4.36M 0.06%
216,171
-15,021
-6% -$299K
ECL icon
230
Ecolab
ECL
$75.6B
$4.34M 0.06%
32,332
-100
-0.3% -$13.3K
VCSH icon
231
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$4.22M 0.06%
53,277
+3,531
+7% +$281K
NGG icon
232
National Grid
NGG
$82.7B
$4.2M 0.06%
80,708
+22,304
+38% +$1.19M
NVS icon
233
Novartis
NVS
$295B
$4.11M 0.06%
54,639
+4,240
+8% +$320K
T icon
234
AT&T
T
$165B
$4.04M 0.06%
137,541
-1,455
-1% -$39.7K
ZBH icon
235
Zimmer Biomet
ZBH
$17.7B
$3.95M 0.06%
33,740
+387
+1% +$43.8K
SAP icon
236
SAP
SAP
$187B
$3.79M 0.06%
33,765
+2,965
+10% +$335K
RY icon
237
Royal Bank of Canada
RY
$291B
$3.77M 0.06%
46,180
+1,400
+3% +$111K
EIX icon
238
Edison International
EIX
$30.7B
$3.68M 0.05%
58,210
+1,295
+2% +$98.8K
HD icon
239
Home Depot
HD
$332B
$3.65M 0.05%
19,236
+661
+4% +$114K
IBM icon
240
IBM
IBM
$202B
$3.48M 0.05%
23,692
-1,124
-5% -$163K
MDLZ icon
241
Mondelez International
MDLZ
$77.7B
$3.46M 0.05%
80,759
– –
PSX icon
242
Phillips 66
PSX
$82.9B
$3.42M 0.05%
33,816
-394
-1% -$37.5K
PFE icon
243
Pfizer
PFE
$140B
$3.4M 0.05%
98,857
+1,538
+2% +$52.4K
KMB icon
244
Kimberly-Clark
KMB
$36.4B
$3.32M 0.05%
27,544
– –
MCO icon
245
Moody's
MCO
$81.7B
$3.31M 0.05%
22,450
-140
-0.6% -$20.5K
O icon
246
Realty Income
O
$61.2B
$3.31M 0.05%
59,804
+1,057
+2% +$57.3K
CTXS
247
DELISTED
Citrix Systems Inc
CTXS
$3.28M 0.05%
37,310
+2,415
+7% +$205K
SNN icon
248
Smith & Nephew
SNN
$12.9B
$3.18M 0.05%
90,880
+10,880
+14% +$396K
VZ icon
249
Verizon
VZ
$194B
$3.03M 0.04%
57,169
-1,285
-2% -$63.2K
ACC
250
DELISTED
American Campus Communities, Inc.
ACC
$3.02M 0.04%
73,582
-867
-1% -$37K
8 9
10
11 12

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.